GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stella Pharma Corp (TSE:4888) » Definitions » Cost of Goods Sold

Stella Pharma (TSE:4888) Cost of Goods Sold : 円52.2 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Stella Pharma Cost of Goods Sold?

Stella Pharma's cost of goods sold for the three months ended in Sep. 2024 was 円0.0 Mil. Its cost of goods sold for the trailing twelve months (TTM) ended in Sep. 2024 was 円52.2 Mil.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Stella Pharma's Gross Margin % for the three months ended in Sep. 2024 was %.

Cost of Goods Sold is also directly linked to Inventory Turnover. Stella Pharma's Inventory Turnover for the three months ended in Sep. 2024 was 0.00.


Stella Pharma Cost of Goods Sold Historical Data

The historical data trend for Stella Pharma's Cost of Goods Sold can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Pharma Cost of Goods Sold Chart

Stella Pharma Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cost of Goods Sold
Get a 7-Day Free Trial - 24.19 15.24 22.12 52.19

Stella Pharma Quarterly Data
Mar19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Cost of Goods Sold Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.29 23.63 6.59 14.68 -

Stella Pharma Cost of Goods Sold Calculation

Cost of Goods Sold is the aggregate cost of goods produced and sold, and services rendered during the reporting period. It excludes Total Operating Expense, such as Depreciation, Depletion and Amortization and Selling, General, & Admin. Expense.

Cost of Goods Sold for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円52.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stella Pharma  (TSE:4888) Cost of Goods Sold Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Stella Pharma's Gross Margin % for the three months ended in Sep. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cost of Goods Sold is also directly linked to another concept called Inventory Turnover:

Stella Pharma's Inventory Turnover for the three months ended in Sep. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher inventory turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate inventory turnover. An average inventory is a better indication.


Stella Pharma Cost of Goods Sold Related Terms

Thank you for viewing the detailed overview of Stella Pharma's Cost of Goods Sold provided by GuruFocus.com. Please click on the following links to see related term pages.


Stella Pharma Business Description

Traded in Other Exchanges
N/A
Address
3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.

Stella Pharma Headlines

No Headlines